Coding and long non-coding gene expression changes in the CNS traumatic injuries

• Published in: Cellular and molecular life sciences : CMLS Vol. 79; no. 2; p. 123
• Main Authors: Wu, Xizi, Wei, Haichao, Wu, Jia Qian
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.02.2022; Springer Nature B.V
• Subjects: Animals; Apoptosis; Biochemistry; Biomedical and Life Sciences; Biomedicine; Brain Injuries, Traumatic - metabolism; Cell activation; Cell Biology; Central nervous system; Gene expression; Gene Expression Regulation; Gene sequencing; Genes; Head injuries; Humans; Injuries; Life Sciences; miRNA; Molecular modelling; Non-coding RNA; Nucleotides; Proteins; Quality of life; Review; Ribonucleic acid; RNA; RNA, Long Noncoding - metabolism; Spinal cord injuries; Spinal Cord Injuries - metabolism; Transcriptome; Transcriptomes; Traumatic brain injury; Spinal cord injury (SCI); Long non-coding RNAs (lncRNAs); RNA-sequencing (RNA-Seq); Traumatic brain injury (TBI); Gene expression
• ISSN: 1420-682X; 1420-9071
• DOI: 10.1007/s00018-021-04092-2

Traumatic brain injury (TBI) and spinal cord injury (SCI) are two main central nervous system (CNS) traumas, caused by external physical insults. Both injuries have devastating effects on the quality of life, and there is no effective therapy at present. Notably, gene expression profiling using bulk RNA sequencing (RNA-Seq) and single-cell RNA-Seq (scRNA-Seq) have revealed significant changes in many coding and non-coding genes, as well as important pathways in SCI and TBI. Particularly, recent studies have revealed that long non-coding RNAs (lncRNAs) with lengths greater than 200 nucleotides and without protein-coding potential have tissue- and cell type-specific expression pattern and play critical roles in CNS injury by gain- and loss-of-function approaches. LncRNAs have been shown to regulate protein-coding genes or microRNAs (miRNAs) directly or indirectly, participating in processes including inflammation, glial activation, cell apoptosis, and vasculature events. Therefore, lncRNAs could serve as potential targets for the diagnosis, treatment, and prognosis of SCI and TBI. In this review, we highlight the recent progress in transcriptome studies of SCI and TBI and insights into molecular mechanisms.